Get the Stockscreener App
4.2244
6.71%
0.2944
Veru Inc stock is traded at $4.2244, with a volume of 115.62K.
It is up +6.71% in the last 24 hours and up +21.55% over the past month.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
See More
Previous Close:
$3.93
Open:
$4.44
24h Volume:
115.62K
Relative Volume:
0.71
Market Cap:
$61.57M
Revenue:
$6.66M
Net Income/Loss:
$-25.52M
P/E Ratio:
-3.4912
EPS:
-1.21
Net Cash Flow:
$-28.98M
1W Performance:
+4.58%
1M Performance:
+21.55%
6M Performance:
-22.73%
1Y Performance:
-51.58%
1-Day Range:
$4.15
$4.44
1-Week Range:
$3.90
$4.59
52-Week Range:
$2.64
$14.20
Veru Inc Stock (VERU) Company Profile
Name
Veru Inc
Sector
Industry
Phone
(312) 595-9123
Address
2916 N. MIAMI AVENUE, MIAMI, FL
Compare VERU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VERU
Veru Inc
|
4.20 | 57.58M | 6.66M | -25.52M | -28.98M | -1.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.75 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
549.47 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
800.40 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.18 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Veru Inc Stock (VERU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-24 | Initiated | B. Riley Securities | Buy |
| Mar-28-24 | Initiated | Raymond James | Outperform |
| Jun-07-23 | Upgrade | Jefferies | Underperform → Hold |
| Apr-13-21 | Initiated | Jefferies | Buy |
| Feb-09-21 | Reiterated | H.C. Wainwright | Buy |
| Jan-21-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-20-19 | Initiated | Oppenheimer | Outperform |
| Jul-03-18 | Initiated | Maxim Group | Buy |
View All
Veru Inc Stock (VERU) Latest News
Will Veru Inc. continue its uptrendWeekly Profit Analysis & Technical Confirmation Alerts - newser.com
Using fundamentals and technicals on Veru Inc.Weekly Risk Report & High Yield Equity Trading Tips - newser.com
Can Veru Inc. hit a new high this monthGap Up & Weekly Momentum Stock Picks - newser.com
Is Veru Inc. still worth holding after the dipWeekly Profit Recap & AI Driven Price Predictions - newser.com
Veru Inc. stock daily chart insights2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
News impact scoring models applied to Veru Inc.Market Performance Report & Verified Short-Term Trading Plans - newser.com
Is Veru Inc. a candidate for recovery playMarket Growth Report & Risk Managed Investment Entry Signals - newser.com
Why global investors buy Veru Inc. (FMW) stockPortfolio Profit Report & Safe Capital Growth Tips - newser.com
Veru (NASDAQ:VERU) Earns "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Why Veru Inc. (FMW) stock stays undervalued2025 Sector Review & High Yield Stock Recommendations - newser.com
October 2025's Noteworthy Penny Stocks - simplywall.st
Veru Inc.'s (NASDAQ:VERU) Share Price Boosted 29% But Its Business Prospects Need A Lift Too - simplywall.st
Should you wait for a breakout in Veru Inc.July 2025 Spike Watch & Safe Entry Point Identification - newser.com
How Veru Inc. (FMW) stock reacts to weak economyWeekly Trend Recap & Comprehensive Market Scan Insights - newser.com
Veru Inc. stock trend outlook and recovery pathBreakout Watch & Safe Capital Investment Plans - newser.com
Published on: 2025-10-05 11:22:58 - earlytimes.in
How to recover losses in Veru Inc. stockQuarterly Profit Report & Daily Profit Focused Screening - newser.com
These small cap stocks are poised for a comeback – Palisade Capital’s Dan Veru - Seeking Alpha
Acute Respiratory Distress Syndrome Market: Epidemiology, Therapies, and Key Players | Veru Inc., Direct Biologics, Athersys, Healios, MediciNova - Barchart.com
Measuring Veru Inc.’s beta against major indicesQuarterly Market Review & Capital Efficiency Focused Strategies - newser.com
What analysts say about Veru Inc FMW stockAnalyst Downgrades & Small Budget Trading Tips - earlytimes.in
What drives Veru Inc stock priceTake Profit Strategies & Turn Data into Profits With Our Strategies - earlytimes.in
Onconetix Completes $12.9M Private Placement - The Globe and Mail
Is Veru Inc a good long term investmentCovered Call Writing & Free Significant Capital Appreciation - earlytimes.in
Veru Settles Debt with Onconetix Agreement - TipRanks
Veru settles $8.8 million debt with Onconetix for cash, preferred stock, and warrants - Investing.com Australia
Veru settles $8.8 million debt with Onconetix for cash, preferred stock, and warrants By Investing.com - Investing.com South Africa
Veru Inc Stock (VERU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Veru Inc Stock (VERU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rankowitz Michael L | Director |
Feb 19 '25 |
Buy |
0.58 |
54,721 |
31,919 |
250,000 |
0.21%
2.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):